Siddharth Sheth, MD

Siddharth Sheth, MD



Research & Career Path:
Clinical Trials/Translational Research in Head and Neck Cancer, Immunotherapy

Publications During Fellowship:
Stepp WH, Farquhar D, Sheth S, et al. RNA Oncoimmune Phenotyping of HPV-Positive p16-Positive Oropharyngeal Squamous Cell Carcinomas by Nodal Status. JAMA Otolaryngol Head Neck Surg. Published online April 18, 2018. doi:10.1001/jamaoto.2018.0602

Sheth SH and Weiss JM. Pembrolizumab and its use in the treatment of recurrent or metastatic head and neck cancer. Future Oncol. 2018 Feb 21. doi: 10.2217/fon-2017-0628.

Sheth S, Farquhar D, Major B, Zevallos JP, Hayes DN. Alterations in the KEAP1/CUL3/NFE2L2 pathway is associated with radiation failure in laryngeal squamous cell carcinoma. Under Review. 

Farquhar D, Masood M, Sheth S, Weissler M, Zevallos J, Olshan A. Travel time to provider is associated with advanced stage at presentation in head and neck squamous cell carcinoma. Under Review.

Masood M, Farquhar D, Sheth S, Zanation M, Olshan A, Hackman T. Survival outcomes of surgically treated patients with head and neck cancer based on type of treatment center and surgical volume

Awards:
North Carolina Oncology Alliance Outstanding Fellow Award, 2017, 2018
ASCO/AACR Methods in Clinical Cancer Research Workshop Participant, 2017

Grants:
Grant: AACR-AstraZeneca-MedImmune Early Phase Clinical Immuno-oncology Training FellowshipLocation: Gaithersburg, Maryland
Award Date: 2018-2019

Meetings:  Abstracts Presented:
ASTRO Multiciplinary Head and Neck Symposium, ASCO

Filed under: